New Research on Sperm Stem Cells has Implications for Male Infertility
Credit: Huntsman Cancer Insitute
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah and collaborators at University of Utah Health (U of U Health) sheds light on the complex process that occurs in the development of human sperm stem cells. This is the first study to characterize the changes human sperm stem cells undergo as they mature. The results have implications for understanding male infertility as well as cancer development and were published in the journal Cell Stem Cell.
Previous studies of sperm stem cells have been limited to model systems, including mice. But this first study of developing human sperm stem cells revealed this process was much more complex in humans than had been previously understood. Using genome analysis tools, scientists outlined the multistage process that sperm stem cells undergo during their normal development.
“This information yields new insights into how sperm stem cells function and develop under normal circumstances,” says the study’s lead author Bradley Cairns, PhD, senior director of basic science at HCI and professor and chair of oncological sciences at the U of U. “We have built a very important framework we can now use to help us understand what happens when things go wrong, resulting in issues like infertility and cancer in men.”
In the study, scientists examined all of the genes that turn ‘on’ or ‘off’ in any given cell during normal development. Using single cell RNA sequencing analysis, the Cairns lab profiled cells individually, establishing the gene expression profile in human sperm stem cells.
Their findings outlined four distinct cellular phases of sperm stem cells maturation, revealing how the stem cells progress from a “quiescent” state, to a “proliferation” state during which stem cells divide, to a final “differentiation” state when stem cells mature to become sperm. Specifically, the data reveal distinct transitions in factors that influence the different cellular states including cell cycle regulators, transcription factors, and signaling factors.
“Working with my patients with infertility, I have seen how devastating this diagnosis can be,” says co-author and reproductive urologist James Hotaling, MD, also an assistant professor of surgery at U of U Health. “This study will help us understand what causes infertility in some cases.”
The results may also have implications for understanding how some cancers arise. Men with infertility are known to be at higher risk for certain cancers including testicular and prostate cancers. “Our study sheds new light on how genes normally function in sperm stem cells,” says Cairns. “The next steps will be to use this knowledge to better understand what changes happen when sperm stem cells don’t develop normally and instead convert into cancer cells.”
The authors believe the results of the study could lead to better tools for diagnosing and treating patients with male infertility, as well as uncovering the complicated genetic changes that underlie cancers associated with male infertility.
This study was funded by the National Institutes of Health/National Cancer Institute P30 CA042014, the Howard Hughes Medical Institute, the University of Utah, and the Huntsman Cancer Foundation.
This article has been republished from materials provided by Huntsman Cancer Institute. Note: material may have been edited for length and content. For further information, please contact the cited source.
Guo, J., Grow, E. J., Chongil, Y. et al. (2017). Transcription, Signaling and Metabolic Transitions During Human Spermatogonial Stem Cell Differentiation. Cell Stem Cell, 21(4), 533-546. doi.org/10.1016/j.stem.2017.09.003
Targeting Epigenetic Proteins to Prevent Breast CancerNews
Researchers have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study suggests that inhibiting these proteins with drugs could prevent the development of breast cancer in women at high risk of the disease.READ MORE
Cell Technology Used to Treat Osteochondral Knee DefectNews
Autologous cells of stromal vascular fraction were transplanted to a 36-year-old man with the use of fibrin matrix.READ MORE